Hosted on MSN25m
RBC Capital Downgrades Pliant Therapeutics (PLRX)Fintel reports that on February 10, 2025, RBC Capital downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback